The expression of seven 14-3-3 isoforms in human meningioma

Brain Research

Volumn 1336, Issue , 2010, Pages 98-102

  Liu, Yang ^a   Tian, Rui feng ^b   Li, Yun ming ^b   Liu, Wei ping ^a   Cao, Lei ^a   Yang, Xiao liang ^a   Cao, Wei dong ^a   Zhang, Xiang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

14 3 3 isoforms; Immunohistochemistry; Meningioma

Indexed keywords

PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 ETA; PROTEIN 14 3 3 GAMMA; PROTEIN 14 3 3 THETA; PROTEIN 14 3 3 ZETA; STRATIFIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; CHILD; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD;

14-3-3 PROTEINS; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EUKARYOTA;

EID: 77952239767     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.009     Document Type: Article

References (31)

1. Aitken A., Collinge D.B., van Heusden B.P.H., Isobe T., Roseboom P.H., Rosenfeld G., and Soll J. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem. Sci. 17 (1992) 498-501
2. Arora S., Matta A., Shukla N.K., Deo S.V., and Ralhan R. Identification of differentially expressed genes in oral squamous cell carcinoma. Mol. Carcinog. 42 (2005) 97-108
3. Baldin V. 14-3-3 proteins and growth control. Prog. Cell Cycle Res. 4 (2000) 49-60
4. Baxter H.C., Fraser J.R., Liu W.-G., Forster J.L., Clokie S., Steinacker P., Otto M., Bahn E., Wiltfang J., and Aitken A. Specific 14-3-3 isoform detection and immunolocalization in prion diseases. Biochem. Soc. Trans. 30 (2002) 387-391
5. Boston P.F., Jackson P., Kynoch P.A.M., and Thompson R.J. Purification, properties, and immunohistochemical localisation of human brain 14-3-3 protein. J. Neurochem. 38 (1982) 1466-1474
6. Cao W.D., Zhang X., Zhang J.N., Yang Z.J., Zhen H.N., Cheng G., Li B., and Gao D. Immunocytochemical detection of 14-3-3 in primary nervous system tumors. J. Neurooncol. 77 (2006) 125-130
7. Ferl R.J., Manak M.S., and Reyes M.F. The 14-3-3 s. Genome Biol. 3 (2002) (REVIEWS3010)
8. Fu H., Subramanian R.R., and Masters S.C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 617-647
9. Hermeking H. The 14-3-3 cancer connection. Nat. Rev. Cancer 3 (2003) 931-943
10. Hosing A.S., Kundu S.T., and Dalal S.N. 14-3-3 Gamma is required to enforce both the incomplete S phase and G2 DNA damage checkpoints. Cell Cycle. 7 (2008) 3171-3179
11. Jin Y., Dai M.S., Lu S.Z., Xu Y., Luo Z., Zhao Y., and Lu H. 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J. 25 (2006) 1207-1218
12. Kawamoto Y., Akiguchi I., Nakamura S., Honjyo Y., Shibasaki H., and Budka H. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J. Neuropathol. Exp. Neurol. 61 (2002) 245-253
13. Laronga C., Yang H.Y., Neal C., and Lee M.H. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J. Biol. Chem. 275 (2000) 23106-23112
14. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., and Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114 (2007) 97-109
15. Martin H., Patel Y., Jones D., Howell S., Robinson K., and Aitken A. Antibodies against the major brain isoforms of 14-3-3 protein. An antibody specific for the N-acetylated amino-terminus of a protein. FEBS Lett. 331 (1993) 296-303
16. Nomura M., Shimizu S., Sugiyama T., Narita M., Ito T., Matsuda H., and Tsujimoto Y. 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J. Biol. Chem. 278 (2003) 2058-2065
17. Pozuelo R.M., Geraghty K.M., Wong B.H., Wood N.T., Campbell D.G., Morrice N., and Mackintosh C. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem. J. 379 (2004) 395-408
18. Ravagnan L., Roumier T., and Kroemer G. Mitochondria, the killer organelles and their weapons. J. Cell. Physiol. 192 (2002) 131-137
19. Robb V.A., Li W., and Gutmann D.H. Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression. Oncogene 23 (2004) 3589-3596
20. Samuel T., Weber H.O., Rauch P., Verdoodt B., Eppel J.T., McShea A., Hermeking H., and Funk J.O. The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax. J. Biol. Chem. 276 (2001) 45201-45206
21. Su T.T., Parry D.H., Donahoe B., Chien C.-T., O'Farrell P.H., and Purdy A. Cell cycle roles for two 14-3-3 proteins during Drosophila development. J. Cell Sci. 114 (2001) 3445-3454
22. Sunayama J., Tsuruta F., Masuyama N., and Gotoh Y. JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol. 170 (2005) 295-304
23. Sugiyama A., Miyagi Y., Komiya Y., Kurabe N., Kitanaka C., Kato N., Nagashima Y., Kuchino Y., and Tashiro F. Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo. Carcinogenesis 24 (2003) 1549-1559
24. Takihara Y., Matsuda Y., and Hara J. Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 21 (2000) 2073-2077
25. Vercoutter-Edouart A.S., Lemoine J., Le-Bourhis X., Louis H., Boilly B., Nurcombe V., Revillion F., Peyrat J.P., and Hondermarck H. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells. Cancer Res. 61 (2001) 76-80
26. Wang Y., Jacobs C., Hook K.E., Duan H., Booher R.N., and Sun Y. Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. Cell Growth Differ. 11 (2000) 211-219
27. Wanzel M., Kleine-Kohlbrecher D., Herold S., Hock A., Berns K., Park J., Hemmings B., and Eilers M. Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage. Nat. Cell Biol. 7 (2005) 30-41
28. Wilker E., and Yaffe M.B. 14-3-3 Proteins-a focus on cancer and human disease. J. Mol. Cell Cardiol. 37 (2004) 633-642
29. Won J., Kim D.Y., La M., Kim D., Meadows G.G., and Joe C.O. Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis. J. Biol. Chem. 278 (2003) 19347-19351
30. Xing H., Zhang S., Weinheimer C., Kovacs A., and Muslin A.J. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19 (2000) 349-358
31. Yang X., Cao W., Lin H., Zhang W., Lin W., Cao L., Zhen H., Huo J., and Zhang X. Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J. Neurol. Sci. 276 (2009) 54-59